• Article highlight
  • Article tables
  • Article images

Article History

Received : 08-01-2024

Accepted : 07-02-2024



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 333

PDF Downloaded: 256


Get Permission Abhishek M. S. and Nagaraju T. R: A comparative study between 0.5% Ropivacaine with clonidine versus 0.5% Ropivacaine with dexmedetomidine in ultra sound guided supraclavicular brachial plexus block


Introduction

Use of ultrasound guided anaesthesia blocks has been found to be safer and more effective compared to paraesthesia and nerve stimulation techniques.1, 2 Local anaesthetic Ropivacaine has greater degree of motor to sensory differentiation, which may further help in early ambulation.3, 4 Furthermore with the use of adjuvants can extend the period of analgesia. Currently use of ultrasound in blockade of brachial plexus has been well received, which reduces volume and dose of local anaesthetic requirement and avoids complications related to needle placements.5, 6, 7, 8, 9, 10, 11, 12, 13 This study is intended to compare the efficacy between dexmedetomidine and clonidine with 0.5% ropivacaine following supraclavicular brachial plexus block for upper limb surgeries with the help of ultrasound. The primary objective of the study was to check the onset of sensory and motor blockade, duration and quality of sensory and motor blockade. The secondary objective was to assess the hemodynamic variables, any side effects related to the drug used and the technique employed.

Materials and Methods

After the approval of the institutional ethical committee, the study was implemented as a prospective double – blinded one. Informed written consent was obtained from 90 subjects between the ages of 18 – 60 years of American Society of Anaesthesiologist’s Physical Status Classification I and II. The study participants were allocated randomly. Group A was administered 20 mL of 0.5% ropivacaine with dexmedetomidine 1 mg.kg-1. Group B was given 20 mL of 0.5% ropivacaine with clonidine 1 mg.kg-1. The subjects aged 18 – 60yrs with ASA Physical Status 1 and 2, planned for elective surgeries of lower arm, and at the level of elbow, forearm, and hand were selected for the study. Subjects of ASA Physical Status 3 and 4, neurological deficits, bleeding disorder, infection at the site of injection were excluded from study. Preanaesthetic evaluation was carried out in all patients. Subjects were positioned in supine. Head was turned to contralateral side, under asepsis, brachial plexus block was performed with the aid of ultrasound. Sensory blockade was assessed with pinprick test using 3 – point scale, 0 – Normal sensation, 1 – Loss of sensation of pinprick (analgesia) 2 – loss of sensation of touch (anaesthesia) and motor block evaluated every 2 minutes until 30 minutes after injection using Modified Bromage Scale.14 Grade 0 – No block, total arm and forearm flexion, Grade I – Partial block, total forearm and partial arm flexion, Grade II – Almost complete block, inability to flex the arm and decreased ability to flex the forearm, Grade III – Total block, inability to flex both the arm and forearm.

Onset of sensory block was defined as interval between Ropivacaine administration and complete sensory block. Duration of sensory block was defined interval between Ropivacaine administration and complete resolution of anaesthesia. Onset of motor block defined as the interval between the end of Ropivacaine administration and complete motor block. Duration of motor block was defined as interval between Ropivacaine administration and complete resolution of motor block. Inability to move arm and forearm was defined as complete motor bock. Hemodynamic variables were recorded every 5 minutes till completion of the procedure. Adverse effects were corrected with appropriate measures.

Statistical analysis: Simple randomization was implemented. The study period was approximately 6 months.

Randomization was done by using a computer-generated random number table. A sample size of 90 was arrived at using the formula mentioned below. Sample size was decided in consultation with a statistician. After observing results of similar studies (Swami and colleagues), it was considered that a clinically significant benefit of using dexmedetomidine would be a prolongation in sensory block duration by 40% compared with the clonidine group. Based on this, we calculated a sample size that would permit a type I error of α=0.05 and power of 80%. Enrollment of 45 patients in each group was required.15

The formula employed to arrive at the sample size:

Sample size= Z2* (p) * (1 - p)c2

Where:

Z = Z value

p = percentage picking a choice,

c = confidence interval

The data was formulated using MS Excel and interpreted using SPSS 22 software. Results were expressed as mean, median, mode, standard deviation and proportions. Since the data doesn’t follow normality, the non-parametric tests are applied. The Wilcoxon – Mann – Whitney U test was employed to determine whether there was a statistical difference among the groups. Friedman test was applied to find the difference within the group. P value of < 0.05 was contemplated to be significant.

Post – operative pain was noted using Visual Analogue Scale. 0 – Patients does not complain of pain, 1 – 3: Patient complaining of mild pain, 4 – 6: Patients complaining of moderate pain, 7 – 8: Patient complaining of severe pain, 9 – 10: Patient complaining of excruciating pain. Rescue analgesia of diclofenac sodium 75mg intramuscularly was administered when patient visual analogue score is >4.

Results

The study groups were comparable with respect to age, gender, weight, duration of surgery (Table 1). Sensory onset of block in Group A: None (0%) of the patients belonged to the onset sensory of 6 minutes, the majority of the patients 33 (73.3%) belongs to 8 minutes of onset sensory, 12 (26.7%) patients between 10 minutes. Group B: 20 (44.4%) of the patients belonged to the onset sensory of 8 minutes of onset sensory, 12 (26.7%) patients between 10 minutes. The Mean and Standard deviation of sensory onset in Group A: 8.53 ± 0.89 with mean rank 56.33, and Group B: 7.33 ± 1.35, with mean rank of 34.67. Comparing of both groups using Mann – Whitney – U test statistic = 525.0, p value 0.000, since p <0.05, it indicates there is a significant difference in sensory onset between the groups (Table 2).

Table 1

Data in mean standard deviation

Demographics

A(n=45)

B(n=45)

P value

Age

46.4±4.42

43±4.85

0.487

Gender M/F

24/21

23/22

0.675

ASA I/II

25/20

26/19

0.344

Weight (mean)

68.12

65.45

0.652

Duration of surgery in min

106±7

113±10

0.432

Table 2

Onset of sensory block

Onset sensory

Mean

Median

Mode

SD

Min

Max

Mean Rank

Sum of Ranks

Mann-Whitney U

P value

Group A

8.53

8.0

8.0

0.89

8

10

56.33

2535.0

525.0

0.000

Group B

7.33

8.0

6.0

1.35

6

10

34.67

1560.0

Table 3

Onset of motor block

Onset motor

Mean

Median

Mode

SD

Min

Max

Mean Rank

Sum of Ranks

Mann-Whitney U

P value

Group A

13.22

12.0

12.0

1.31

12

15

61.50

2767.5

292.5

0.000

Group B

10.93

10.0

10.0

1.45

8

14

29.50

1327.5

The Mean and Standard deviation of onset of motor block in Group A: 13.22 ± 1.31 with mean rank 61.50, and Group B: 10.93 ± 1.45, with mean rank 29.50. Comparing of both groups using Mann – Whitney – U test statistic = 292.5, p value 0.000, since p <0.05 there is a significant difference in motor onset among the groups (Table 3).

The Mean and Standard deviation of sensory duration in Group A: 394.7 ± 61.6 with mean rank 23.0, and Group B631.3 ± 47.3, with mean rank 68.0. Comparing of both groups using Mann – Whitney – U test statistic = 1.000, p value 0.000, since p<0.05 there is a significant difference in sensory blockade (Table 4).

Table 4

Duration of sensory block

Sensory Duration

Mean

SD

P value

Group A

394.7

61.6

0.0000

Group B

631.3

47.3

The Mean and Standard deviation of motor duration in Group A: 548.7 ± 37.6 with mean rank 27.2, and Group B 606.4 ± 33.0, with mean rank 63.8. Comparing of both groups using Mann – Whitney – U test = 191.0, p value 0.000, since p <0.05 there is a significant difference in motor duration (Table 5).

Table 5

Duration of motor block

Motor Duration

Mean

SD

P value

Group A

548.7

37.6

0.0000

Group B

606.4

33.0

The Mean and Standard deviation of analgesia duration in Group A: 413.8 ± 61.8 with mean rank 23.0, and Group B 1054.9 ± 96.6, with mean rank 68.0. Comparing of both groups using Mann – Whitney – U test statistic = 0.000, p value 0.000, since p <0.05 there is a significant difference in analgesia duration (Table 6).

Table 6

Duration of analgesia

Analgesia

Mean

SD

P value

Group A

413.8

61.8

0.0000

Group B

1054.9

96.6

Discussion

In our study, the demographic data as regards to age, weight, height, sex, ASA physical status and duration of surgery were compared and the differences between the parameters between two groups were statistically not significant. This prospective study was done to evaluate the onset of sensory block, onset of motor blockade, duration of sensory and motor blockade, duration of analgesia and time for rescue analgesia and side effects of dexmedetomidine with ropivacaine vs clonidine with ropivacaine given by ultrasound guided brachial plexus block approach for elective upper limb forearm and hand surgeries. Ultrasound helped to visualize the nerves, needle and spread of local anaesthetic at the brachial plexus block site. Caliber of block and span of postoperative analgesia can be boosted by various adjuvants. The period of sensory and motor block was significant in our study. Enhanced prolongation of sensory and motor blockade when dexmedetomidine and clonidine was used has been reported in earlier studies.

In our study, the dexmedetomidine group (Group B), showed faster onset of sensory block, 7.33 ± 1.35 minutes, faster onset of motor block, 10.93 ± 1.45 minutes, whereas in clonidine group (Group A) showed a delayed onset of sensory block, 8.53 ± 0.89 minutes and motor block of 13.22 ± 1.31 minutes.

Kenan Kaygusuz MD et al and Singelyn FJ et al, Chakraborthy S et al conducted a study with a small dose (30 mg) of clonidine as adjuvant to 0.5% bupivacaine significantly prolonged the duration of analgesia without producing any adverse effects other than sedation.16, 17, 18 The use of dexmedetomidine resulted in faster onset of sensory and motor block. The role of clonidine as adjuvant to ropivacaine in faster onset of sensory and motor block is controversial, while previous date showed no effect on onset of block but with the use of dexmedetomidine with local anaesthetics have shortened the onset time of sensory and motor block.19, 20 Singh S et al conducted study with clonidine and dexmedetomidine as adjuvants to local anaesthetics found adjuvants were added to Ropivacaine for supraclavicular brachial plexus blocks shorten the onset times for sensory and motor blocks and prolong the duration of motor block and duration of analgesia. Both Clonidine and Dexmedetomidine have the added advantage of conscious sedation, hemodynamic stability, and minimal side effects which makes them a potential adjuvant for nerve blocks.21

Regional anaesthesia makes a simple demand that the appropriate dose of the drug to be given in the correct place. The principal challenge encountered during our study was the unreliability of conventional methods for confirming precise nerve demarcation due to anatomical variation. The real – time ultrasound has been used to localize the peripheral nerve or plexus, accurate needle placement and confirmation of local anaesthetic spread in the appropriate tissue planes. Most comparative studies have shown faster onset times and longer duration of blocks when real-time ultrasound has aided the technique in comparison with other nerve localisation techniques.

In present study it was found that addition of clonidine and dexmedetomidine to 0.5% ropivacaine are effective in supraclavicular brachial plexus block. However, dexmedetomidine is a better alternative to clonidine to obtain early onset and prolonged duration of sensory and motor block and postoperative analgesia. The difference in the need of rescue analgesia between the two groups is statistically highly significant. The observation suggests that patients who were given Ropivacaine + Dexmedetomidine needed much less rescue analgesia as compared to the group who received Ropivacaine + Clonidine.

The difference in the need of rescue analgesia between the two groups Group C and Group D is statistically highly significant (p-value <0.001). The observation suggests that patients who were given Ropivacaine + Dexmedetomidine needed much less rescue analgesia as compared to the group who received Ropivacaine + Clonidine.

Conclusion

Dexmedetomidine is a better adjuvant than clonidine for brachial plexus blocks when added to ropivacaine. Compared to clonidine, dexmedetomidine provides faster onset of sensory/motor block, longer post-operative analgesia, and comparable intra-operative sedation and side effects. The mechanism of action appears to be peripheral rather than central. Dexmedetomidine enhances the duration and quality of the nerve block, making it a valuable adjuvant for peripheral nerve blocks with local anaesthetics. Dexmedetomidine and local anaesthetic agents have a synergistic action. When used with ropivacaine in an ultrasound – guided brachial plexus block, we examined the effectiveness of clonidine and dexmedetomidine as adjuvants. When compared to clonidine, dexmedetomidine has the advantage of a faster onset of the sensory and motor block. It was determined that the creation of intra-operative sedation and adverse effects were equivalent between clonidine and dexmedetomidine. Dexmedetomidine and clonidine enhanced the calibre of the block. The action of dexmedetomidine was presumably local rather than centrally mediated. However, dexmedetomidine was found to be a better alternative to clonidine to obtain early onset and enhanced interval of sensory and motor block and postoperative pain relief. Regardless of mechanism of action, dexmedetomidine was found to be a valuable adjuvant for peripheral nerve blocks when added to local anaesthetic solution.

Source of Funding

None.

Conflict of Interest

None.

Acknowledgments

We thank all the patients for their valuable support.

References

1 

AT Gray Atlas of Ultrasound-Guided Regional Anesthesia: Expert Consult Elsevier Health SciencesUSA2012746

2 

K Gupta V Tiwari PK Gupta MN Pandey AB Singhal G Shubham Clonidine as an adjuvant for ultrasound guided supraclavicular brachial plexus block for upper extremity surgeries under tourniquet: A clinical studyJ Anaesthesiol Clin Pharmacol201430405337

3 

U Bafna N Yadav M Khandelwal T Mistry CS Chatterjee R Sharma Comparison of 0.5% ropivacaine alone and in combination with clonidine in supraclavicular brachial plexus blockIndian J Pain2015291415

4 

QE Ali L Manjunatha SH Amir S Jamil A Quadir Efficacy of clonidine as an adjuvant to ropivacaine in supraclavicular brachial plexus block: A prospective studyIndian J Anaesth20142014670913

5 

O Nazir AH Bhat T Sharma A Khatuja R Misra Comparison of clonidine and dexmedetomidine as adjuvants for ropivacaine in supraclavicular brachial plexus blockSri Lank J of Anaesth2019271538

6 

S Singh A Aggarwal A randomized controlled double-blinded prospective study of the efficacy of clonidine added to bupivacaine as compared with bupivacaine alone used in supraclavicular brachial plexus block for upper limb surgeriesIndian J Anaesth20105465527

7 

CM Brummett MA Norat JM Palmisano R Lydic Perineural administration of dexmedetomidine in combination with Bupivacaine enhances sensory and motor blockade in sciatic nerve block without inducing neurotoxicity in ratAnesthesiology2008109350211

8 

GE Kanazi MT Aouad SL Abbour - Khoury Al Jazzar MM Alameddine R Al-Yaman Effects of low dose Dexmedetomidine or clonidine on characteristics of spinal blockActa Anaesthesiol Scand20065022227

9 

T Yoshitomi A Kohjitani S Maeda H Higchi M Shimada T Miyawaki Dexmedetomidine enhances the local anaesthetic action of lidocaine via an alpha 2A adrenoceptorAnesth Analg2008107196101

10 

A Tripathi K Sharma M Somvanshi RL Samal A comparative study of clonidine and dexmedetomidine as an adjuvant to bupivacaine in supraclavicular brachial plexus blockJ Anaesthesiol Clin Pharmacol20163233448

11 

S Kohli M Kaur S Sahoo H Vajifdar P Kohli Brachial plexus block: Comparison of two different doses of clonidine added to bupivacaineJ Anaesthesiol Clin Pharmacol20132944915

12 

B Baji T Vandana RS Chaudhri D Anand A comparative study of effects of Clonidine added to Ropivacaine versus plain Ropivacaine during supraclavicular brachial plexus blockJ Evol Med Dent Sci201352210235

13 

SS Routray D Biswal K Raut D Mishra The Effects of Clonidine on Ropivacaine in Supraclavicular Brachial Plexus BlockSch J App Med Sci20131688793

14 

D Craig F Carli Bromage motor blockade score - a score that has lasted more than a lifetimeCan J Anesth201865837838

15 

SS Swami VM Keniya SD Ladi R Rao Comparison of dexmedetomidine and clonidine (α2 agonist drugs) as an adjuvant to local anaesthesia in supraclavicular brachial plexus block: a randomised double-blind prospective studyIndian J Anaesth20125632439

16 

K Kaygusuz IO Kol C Duger S Gursoy H Ozturk U Kayacan Effects of Adding Dexmedetomidine to Levobupivacaine in Axillary Brachial plexus BlockCurr Ther Res Clin Exp201273310311

17 

FJ Singelyn M Dangoisse S Bartholomee JM Gouverneur Adding clonidine to mepivacaine prolongs the duration of anaesthesia and analgesia after brachial plexus blockReg Anesth199217314850

18 

S Chakraborty J Chakrabarti M C Mandal Effect of clonidine as adjuvant in bupivacaine induced supraclavicular brachial plexus block: A randomized controlled trialIndian J Pharmacol20104227481

19 

R Jaiswal T Bansal S Mehta G Ahlawat A study to evaluate the effect of adding clonidine to ropivacaine for axillary plexus blockadeAsia J of pharm and clini resea2013316568

20 

D Marhofer SC Kettner P Marhofer S Pils M Weber M Zeitlinger Dexmedetomidine as an adjuvant to ropivacaine prolongs peripheral nerve block: a volunteer studyBr J Anaesth2013110343842

21 

S Singh A Aggarwal A randomized controlled double blinded prospective study of the efficacy of clonidine added to bupivacaine as compared with bupivacaine alone used in supraclavicular brachial plexus block for upper limb surgeriesInd J Anaesth20105465527



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.